4. Issues of Ethnopharmacology in HIV Management
Disease Progression and Clade
An analysis by Kiwanuka and colleagues reported that Ugandans infected with clade D—and recombinant strains that include it—developed AIDS sooner than those infected with clade A and, in the absence of antiretroviral therapy, died sooner.
The investigators suggested that clade D is more virulent because it binds to immune cells more effectively.[Kiwanuka 2008] A study by Baeten and colleagues added support to this finding, with its demonstration that Kenyan women infected with clade D had more than twice the risk of mortality over 6 years vs those infected with clade A. [Baeten 2007] Furthermore, an earlier study of sex workers in Senegal, reported that women infected with clade C, D, or G were more likely to develop AIDS within 5 years after infection than those infected with clade A. [Kanki 1999]
Several studies performed in Thailand suggest that patients infected with CRF A/E viruses are more likely to develop AIDS-defining conditions or die more quickly than those infected with clade B, in the absence of antiretroviral therapy. [Nelson 2007, Rangsin 2007, Costello 2005]
Transmission Differences
A study by Taylor and colleagues reported that some HIV clades and CRFs are predominantly associated with particular modes of transmission[Taylor 2008]—eg, clade B is transmitted primarily through male-to-male sexual contact and intravenous drug use (ie, via blood) and clade C and CRF A/E more likely to be transmitted by heterosexual contact (ie, via a mucosal route). However, a number of other studies have reached conflicting conclusions about the biological causes that may explain these and other observed differences in transmission routes among HIV-1 clades and CRFs. [Bhoopat 2001, Essex 1999, Pope 1997, Dittmar 1997, Yang 2003, Blackard 2001, Renjifo 2004, Murray 2000, Tranchat 1994, Tàpia 2003, Martinez 2006]